Analyst Consensus of $2.89 EPS in Focus for Intuitive Surgical, Inc. (NASDAQ:ISRG)

As the next earnings season comes into focus, investors will be watching to see which companies surpass expectations. Many investors consider earnings performance to be one of the most important factors when deciding which stocks to choose. When quarterly earnings numbers are released, the investing community closely watches to see if a company beats or misses projections. Tracking some earnings projections, we note that the current quarter EPS consensus estimate for Intuitive Surgical, Inc. (NASDAQ:ISRG) is 2.89. This EPS estimate is using data provided by 4 sell-side analysts polled by Zacks Research. For the last quarter, the company reported a quarterly EPS of 2.83. Because earnings surprises may cause the stock price to rise or fall drastically in the short term, investors may choose to make the buy/sell decisions after the smoke has cleared.

As many investors probably already know, there is no one way to select winning stocks. There are plenty of different theories and ideas out there, and it may become overwhelming to look at all of them. Individual investors who manage their own money may have to dedicate an ample amount of time to find a strategy that works for them. Understanding portfolio diversification, personal risk tolerance, and time horizon may be a good place for the investor to start. Because there is no guarantee that past performance will indicate future results, investors may have to be willing to come at the market from a few different angles. 

In the fast paced world of stock market investing, individuals are always looking for information to help provide an edge. Many investors will study sell-side analyst opinions to help assist with navigating the market. Turning the attention to shares of Intuitive Surgical, Inc. (NASDAQ:ISRG), we can see that the current average broker rating is now 1.54. This rating is provided by Zacks Research using a scale from 1 to 5. Following this scale, a 1 would indicate a Strong Buy and a 5 would represent a Strong Sell rating. Digging a little deeper, we can see that out of the polled analysts, 11 rated the stock a Strong Buy or Buy. This average broker rating may help investors decide if they feel the same way about the stock as the professionals.

Investors might be trying to gauge which way shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) will swing over the next couple of quarters. In recent trading activity, the stock has been seen near the $502.71 level. Many investors pay increased attention to shares when they are nearing notable historical highs or lows. Over the past 52 weeks, the stock has touched a high price of 574.74, and seen a low price of 381.87. Looking at some additional historical stock price information, we note that shares have seen a move -1.7% over the previous 12 weeks. If we pull in closer to look at performance over the past month, we see that shares have seen a change of 4.35%. Over the last 5 trading sessions, the stock has moved 5.07%. Investors will most likely be keeping their eyes peeled to see how the stock performs heading into the next round of earnings reports.

Doing standard fundamental stock analysis is fairly straightforward. These days, investors have easy access to large amounts of available data. The biggest problem for the average investor may be dedicating the time to actually doing the research. One goal of studying the fundamentals is to establish the true value of a stock compared to how it is currently trading in the marketplace. Many investors believe that identifying quality stocks should be a cornerstone of portfolio construction. Obtaining as much knowledge as possible about a stock can help make the buying decisions a little easier. Some investors may trust other people or products to do the required research, but others may wish to roll up the sleeves and do all the analysis themselves.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.